ACN - 101321555 Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)
Search
Generic filters
Exact text matches only
Search into
Filter by Categories
Research integrity
Filter by Categories
Human Research Ethics

Resource Library

Research Ethics MonthlyAbout Us

ResourcesHuman Research Ethics(US) FDA revokes emergency use ruling for hydroxychloroquine, the drug touted by Trump as a Covid-19 therapy – STAT (Lev Facher | June 2020)

Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

(US) FDA revokes emergency use ruling for hydroxychloroquine, the drug touted by Trump as a Covid-19 therapy – STAT (Lev Facher | June 2020)

 


View full details | Go to resource


WASHINGTON — The Food and Drug Administration on Monday said it had withdrawn an emergency approval for use of the malaria drug hydroxychloroquine as a Covid-19 treatment.

The latest development in the hydroxychloroquine saga.  We have included links to seven related items.

Almost since the beginning of the novel coronavirus pandemic, President Trump and other world leaders have touted hydroxychloroquine as an effective treatment based on scattered anecdotes, not reliable scientific studies. But the FDA said Monday that the drug, along with chloroquine, is “unlikely to be effective in treating Covid-19,” and highlighted “serious side effects.”
.

The FDA’s withdrawal of the emergency use order, which Politico first reported, appears to formally close the door on U.S. officials’ willingness to use the drug to prevent or treat Covid-19, the disease caused by the novel coronavirus.

Read the rest of this discussion piece



Related Reading

Resources Menu

Research Integrity


Human Research Ethics

0